IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INAB IN8bio, Inc.

交易中 12-16 10:14:36 EST

1.57

-0.03

-2.19%

最高1.57	最低1.55	成交量4,792
今开1.55	昨收1.60	日振幅0.94%
总市值725.28万	流通市值669.37万	总股本463.44万
成交额7,443	换手率0.11%	流通股本427.71万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"INAB","market":"US","secType":"STK","nameCN":"IN8bio, Inc.","latestPrice":1.565,"timestamp":1765897865240,"preClose":1.6,"halted":0,"volume":4792,"delay":0,"floatShares":4277100,"shares":4634400,"eps":-9.543181,"marketStatus":"交易中","change":-0.035,"latestTime":"12-16 10:14:36 EST","open":1.55,"high":1.565,"low":1.55,"amount":7442.9449424,"amplitude":0.009375,"askPrice":1.59,"askSize":100,"bidPrice":1.54,"bidSize":70,"shortable":3,"etf":0,"ttmEps":-9.543181,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765918800000},"marketStatusCode":2,"adr":0,"listingDate":1605157200000,"exchange":"NASDAQ","adjPreClose":1.6,"preHourTrading":{"tag":"盘前","latestPrice":1.58,"preClose":1.6,"latestTime":"09:26 EST","volume":3,"amount":4.74,"timestamp":1765895190930},"postHourTrading":{"tag":"盘后","latestPrice":1.6032,"preClose":1.6,"latestTime":"16:38 EST","volume":622,"amount":993.3368,"timestamp":1765834691303},"volumeRatio":0.761031},"requestUrl":"/m/hq/s/INAB/tweets","defaultTab":"tweets","newsList":[{"id":"2584998908","title":"In8Bio, Inc.盘中异动 早盘急速上涨5.01%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584998908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584998908?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:43","pubTimestamp":1763477032,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时43分，In8Bio, Inc.股票出现异动，股价大幅上涨5.01%。截至发稿，该股报1.67美元/股，成交量7252股，换手率0.16%，振幅2.77%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118224352a7022984&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118224352a7022984&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2572681595","title":"In8Bio, Inc.盘中异动 早盘快速上涨7.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572681595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572681595?lang=zh_cn&edition=full","pubTime":"2025-10-03 21:35","pubTimestamp":1759498504,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日21时35分，In8Bio, Inc.股票出现波动，股价快速上涨7.77%。截至发稿，该股报2.47美元/股，成交量4389股，换手率0.10%，振幅7.77%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003213504a4526548&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003213504a4526548&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2569057794","title":"In8Bio, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569057794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569057794?lang=zh_cn&edition=full","pubTime":"2025-09-22 22:26","pubTimestamp":1758551181,"startTime":"0","endTime":"0","summary":"北京时间2025年09月22日22时26分，In8Bio, Inc.股票出现异动，股价急速拉升5.00%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922222621a72f9c4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922222621a72f9c4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2557520124","title":"In8Bio, Inc.盘中异动 急速上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557520124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557520124?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:59","pubTimestamp":1754661552,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时59分，In8Bio, Inc.股票出现波动，股价急速上涨5.22%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808215913a47d6626&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808215913a47d6626&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2557130623","title":"In8Bio, Inc.盘中异动 大幅下挫7.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557130623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557130623?lang=zh_cn&edition=full","pubTime":"2025-08-07 00:34","pubTimestamp":1754498093,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日00时34分，In8Bio, Inc.股票出现波动，股价急速下跌7.33%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807003453a6d6f804&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807003453a6d6f804&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2556809913","title":"In8Bio, Inc.盘中异动 股价大跌5.14%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556809913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556809913?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:49","pubTimestamp":1754315357,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时49分，In8Bio, Inc.股票出现异动，股价大幅跳水5.14%。截至发稿，该股报2.00美元/股，成交量1.8335万股，换手率0.53%，振幅3.79%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508042149179732f919&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508042149179732f919&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2555052229","title":"In8Bio, Inc.盘中异动 早盘快速下跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555052229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555052229?lang=zh_cn&edition=full","pubTime":"2025-07-29 22:17","pubTimestamp":1753798626,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日22时17分，In8Bio, Inc.股票出现异动，股价大幅跳水5.53%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729221706a469d7cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729221706a469d7cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2554777533","title":"In8Bio, Inc.盘中异动 快速上涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554777533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554777533?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:42","pubTimestamp":1753710126,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时42分，In8Bio, Inc.股票出现异动，股价大幅上涨5.32%。截至发稿，该股报2.57美元/股，成交量3.376万股，换手率0.98%，振幅3.28%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728214207a467ddb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728214207a467ddb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2550578164","title":"In8Bio, Inc.盘中异动 临近收盘股价大涨5.24%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550578164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550578164?lang=zh_cn&edition=full","pubTime":"2025-07-09 03:58","pubTimestamp":1752004701,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日03时58分，In8Bio, Inc.股票出现异动，股价快速上涨5.24%。截至发稿，该股报2.21美元/股，成交量5.2228万股，换手率1.52%，振幅4.29%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709035822979eba76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709035822979eba76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2548529812","title":"In8Bio, Inc.盘中异动 下午盘股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548529812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548529812?lang=zh_cn&edition=full","pubTime":"2025-07-03 02:35","pubTimestamp":1751481308,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日02时35分，In8Bio, Inc.股票出现波动，股价快速拉升5.31%。截至发稿，该股报2.18美元/股，成交量15.5671万股，换手率4.52%，振幅5.80%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.02%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703023508a4cbab8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703023508a4cbab8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2543603712","title":"In8Bio, Inc.盘中异动 大幅跳水5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543603712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543603712?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:56","pubTimestamp":1750082212,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时56分，In8Bio, Inc.股票出现异动，股价大幅下跌5.31%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616215652a4ac3e77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616215652a4ac3e77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2543546592","title":"In8Bio, Inc.盘中异动 急速下跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543546592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543546592?lang=zh_cn&edition=full","pubTime":"2025-06-13 00:17","pubTimestamp":1749745047,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日00时17分，In8Bio, Inc.股票出现波动，股价快速下跌5.12%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613001727a705a9c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613001727a705a9c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2542934872","title":"In8Bio, Inc.盘中异动 早盘急速下挫5.19%报2.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542934872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542934872?lang=zh_cn&edition=full","pubTime":"2025-06-10 21:51","pubTimestamp":1749563460,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日21时51分，In8Bio, Inc.股票出现异动，股价快速下跌5.19%。截至发稿，该股报2.92美元/股，成交量5.3605万股，换手率1.56%，振幅5.50%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506102151019516611f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506102151019516611f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2542801103","title":"In8Bio, Inc.盘中异动 急速下挫21.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542801103","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542801103?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:31","pubTimestamp":1749475895,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时31分，In8Bio, Inc.股票出现异动，股价快速跳水21.10%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609213135a700af3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609213135a700af3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2540577770","title":"In8Bio, Inc.盘中异动 快速下跌5.39%报0.127美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540577770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540577770?lang=zh_cn&edition=full","pubTime":"2025-06-03 22:14","pubTimestamp":1748960095,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日22时14分，In8Bio, Inc.股票出现异动，股价大幅下跌5.39%。截至发稿，该股报0.127美元/股，成交量203.984万股，换手率2.25%，振幅5.46%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603221456a6f8c918&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603221456a6f8c918&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2540795776","title":"In8Bio, Inc.盘中异动 早盘股价大跌9.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540795776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540795776?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:31","pubTimestamp":1748871100,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时31分，In8Bio, Inc.股票出现波动，股价大幅下挫9.38%。截至发稿，该股报0.134美元/股，成交量835.554万股，换手率9.20%，振幅0.20%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213140a6f7234f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213140a6f7234f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2539265736","title":"In8Bio, Inc.盘中异动 急速上涨5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539265736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539265736?lang=zh_cn&edition=full","pubTime":"2025-05-29 21:39","pubTimestamp":1748525974,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日21时39分，In8Bio, Inc.股票出现波动，股价快速上涨5.63%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505292139349769e3b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505292139349769e3b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2518227447","title":"In8Bio, Inc.盘中异动 早盘大幅拉升6.16%报0.262美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227447","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518227447?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613463,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，In8Bio, Inc.股票出现异动，股价快速拉升6.16%。截至发稿，该股报0.262美元/股，成交量9.8859万股，换手率0.14%，振幅0.12%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213103a26a2430&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213103a26a2430&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2517923787","title":"In8Bio, Inc.盘中异动 下午盘急速上涨5.06%报0.272美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517923787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517923787?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:13","pubTimestamp":1741202030,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时13分，In8Bio, Inc.股票出现波动，股价急速拉升5.06%。截至发稿，该股报0.272美元/股，成交量95.0162万股，换手率1.31%，振幅9.66%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为2.13%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306031350989d8299&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306031350989d8299&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2516677326","title":"In8Bio, Inc.盘中异动 大幅下挫5.77%报0.245美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677326","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677326?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098733,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，In8Bio, Inc.股票出现异动，股价快速下挫5.77%。截至发稿，该股报0.245美元/股，成交量15.6197万股，换手率0.22%，振幅1.62%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223214989bac07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223214989bac07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.in8bio.com","stockEarnings":[{"period":"1week","weight":-0.1011},{"period":"1month","weight":0.0063},{"period":"3month","weight":-0.2079},{"period":"6month","weight":-0.2488},{"period":"1year","weight":-0.8127},{"period":"ytd","weight":-0.7926}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"In8bio, Inc.于2016年2月8日在百慕大注册成立。2018年5月7日，该公司在一项交易中重新并入美国，在该交易中，该公司转变为一家新成立的特拉华州公司，该公司是一家临床阶段生物技术公司，专注于发现、开发和商业化用于实体和液体肿瘤的gamma-delta T细胞候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.075455},{"month":2,"riseRate":0.5,"avgChangeRate":-0.045373},{"month":3,"riseRate":0.25,"avgChangeRate":-0.169384},{"month":4,"riseRate":0.5,"avgChangeRate":-0.068431},{"month":5,"riseRate":0.5,"avgChangeRate":0.261664},{"month":6,"riseRate":0.25,"avgChangeRate":-0.322353},{"month":7,"riseRate":0.5,"avgChangeRate":-0.024632},{"month":8,"riseRate":0.4,"avgChangeRate":-0.149237},{"month":9,"riseRate":0.2,"avgChangeRate":-0.145486},{"month":10,"riseRate":0.4,"avgChangeRate":-0.009603},{"month":11,"riseRate":0.4,"avgChangeRate":-0.077155},{"month":12,"riseRate":0.4,"avgChangeRate":0.078315}],"exchange":"NASDAQ","name":"IN8bio, Inc.","nameEN":"IN8bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供IN8bio, Inc.(INAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"IN8bio, Inc.,INAB,IN8bio, Inc.股票,IN8bio, Inc.股票老虎,IN8bio, Inc.股票老虎国际,IN8bio, Inc.行情,IN8bio, Inc.股票行情,IN8bio, Inc.股价,IN8bio, Inc.股市,IN8bio, Inc.股票价格,IN8bio, Inc.股票交易,IN8bio, Inc.股票购买,IN8bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供IN8bio, Inc.(INAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}